Citations

Clear

4847 citation(s) found for "Yu, Eric".

Comparison of Nuclear Grade, Necrosis, and Histologic Subtype Between Biopsy and Resection in Pleural Malignant Mesothelioma: An International Multi-Institutional Analysis
Schulte, Jefree J. , Chapel, David B. , Attanoos, Richard , Brčić, Luka , Burn, Juliet, Butnor, Kelly J. , Chang, Nina, Chen, Heather , Đačić, Sanja , Godschachner, Theresa, Hiroshima, Kenzo , Klebe, Sonja , Krausz, Thomas, Litzky, Leslie A., Marchevsky, Alberto M. , Mueller, Jeffrey , Nabeshima, Kazuki , Roden, Anja C. , Rørvig, Sara, Santoni‐Rugiu, Eric , Tazelaar, Henry D. , Walts, Ann E. , Weynand, Birgit , Zaizen, Yoshiaki , Zhang, Yu Zhi , Husain, Aliya N. , Santoni-Rugiu, Eric , Tazelaar, Henry, Zhang, Yu Zhi , Zaizen, Yoshiaki , de Perrot, Marc , Fukuoka, Junya , Galateau-Sallé, Françoise , Nicholson, Andrew G. , Pal, Prodipto , Tazelaar, Henry D. , Tsao, Ming‐Sound

Mayo Clinic

American Journal of Clinical Pathology | March 16, 2021 | Volume: 156 | Issue: 6 | Pages: 989-999

10.1093/ajcp/aqab054 | PMID 33978147 Get It

Abstract Objectives Numerous studies on malignant mesothelioma (MM) highlight the prognostic importance of histologic subtype, nuclear grade, and necrosis. This study compares these parameters in paired biopsy and resection specimens of pleural MM. Methods Histologic subtype, percentage of epithelioid morphology, nuclear grade, and the presence or absence of necrosis were compared in 429 paired biopsies and resection specimens of pleural MM from 19 institutions. Results Histologic subtype was concordant in 81% of cases (κ = 0.58). When compared with resection specimens, epithelioid morphology at biopsy had a positive predictive value (PPV) of 78.9% and a negative predictive value (NPV) of 93.5%; sarcomatoid morphology showed high PPV (92.9%) and NPV (99.3%), and biphasic morphology PPV was 89.7% and NPV was 79.7%. Agreement of the percentage of epithelioid morphology was fair (κ = 0.27). Nuclear grade and necrosis were concordant in 75% (κ = 0.59) and 81% (κ = 0.53) of cases, respectively. Nuclear grade showed moderate (κ = 0.53) and substantial (κ = 0.67) agreement from patients with and without neoadjuvant therapy, respectively, and necrosis showed moderate (κ = 0.47 and κ = 0.60) agreement, respectively, in the same subsets of paired specimens. Conclusions Paired biopsy-resection specimens from pleural MM show overall moderate agreement in pathologic parameters. These findings may help guide postbiopsy management and triage of patients with MM.
BRAF V600E Mutation in First-Line Metastatic Colorectal Cancer: An Analysis of Individual Patient Data From the ARCAD Database
Cohen, Romain , Liu, Heshan , Fiskum, Jack, Adams, Richard , Chibaudel, Benoist , Maughan, Tim , Venook, Alan P. , Douillard, Jean‐Yves , Heinemann, Volker , Punt, Cornelis J.A. , Bokemeyer, Carsten , Lenz, Heinz‐Josef , Koopman, Miriam , Zalcberg, John , Grothey, A., Gramont, Aimery de , Shi, Qian , Maughan, Timothy S , Venook, Alan P , Heinemann, Volker , Falcone, Alfredo , Bokemeyer, Carsten , Kaplan, Richard , Lenz, Heinz-Josef , Koopman, Miriam , Shi, Qian , Zalcberg, John , Adams, Richard , Chibaudel, Benoist , Cohen, Romain , Cutsem, Eric Van , Falcone, Alfredo , Kaplan, Richard , Yoshino, Takayuki , André, Thierry

Mayo Clinic

JNCI: Journal of the National Cancer Institute | March 15, 2021 | Volume: 113 | Issue: 10 | Pages: 1386-1395

10.1093/jnci/djab042 | PMID 33734401 Get It

Abstract Background First-line therapeutic strategies for patients with BRAFV600E-mutated (BRAFmt) metastatic colorectal cancer (mCRC) mainly rely on subgroup analyses from randomized controlled trials (RCTs). We aimed to assess the prognostic and predictive impact of BRAFmt on the efficacy of targeted therapies with first-line chemotherapy. Methods Individual patient data from first-line RCTs with BRAF and KRAS status data in the ARCAD database were pooled. Progression-free survival and overall survival (OS) were assessed using Kaplan-Meier and Cox models. Outcomes were compared between treatment groups that were concurrently randomly assigned whenever possible. Results A total of 6391 patients from 10 RCTs were included: 573 BRAFmt (9.0%), 2059 KRASmt (32.2%), and 3759 double wild type (58.8%). BRAFmt mCRC patients experienced statistically significantly poorer OS than those with KRASmt (adjusted hazard ratio [HRadj] = 1.46, 95% confidence interval [CI] = 1.30 to 1.64) and patients with double wild-type tumors (HRadj = 2.14, 95% CI = 1.94 to 2.36). Anti-EGFR agents did not improve progression-free survival or OS of BRAFmt mCRC patients, based on 4 RCTs testing chemotherapy with or without anti-epidermal growth factor receptor (anti-EGFR) (HRadj = 0.96, 95% CI = 0.71 to 1.30; and HRadj = 0.85, 95% CI = 0.66 to 1.14, respectively). Conclusions Our data suggest that the addition of anti-EGFR agents to chemotherapy is ineffective as first-line treatment for BRAFmt mCRC patients.
Robust, flexible, and scalable tests for Hardy–Weinberg equilibrium across diverse ancestries
Kwong, Alan , Blackwell, Thomas W. , LeFaive, Jonathon , Barnes, Kathleen C. , Boerwinkle, Eric , Cade, Brian E. , Chen, Han , Conomos, Matthew P. , Eng, Celeste , Gao, Yan , Irvin, Marguerite R. , Kelly, Tanika N. , Kim, Wonji , Lubitz, Steven A. , Mathias, Rasika A. , Montasser, May E. , Musani, Solomon K., Palmer, Nicholette D, Qiao, Dandi , Reiner, Alex P. , Roden, Dan M. , Shoemaker, M. Benjamin , Smith, Jennifer A. , Smith, Nicholas L. , Lasky‐Su, Jessica , Tiwari, Hemant K., Weeks, Daniel E. , Group, TOPMed Analysis Working, Scott, Laura J. , Smith, Albert V. , Boehnke, Michael , Kang, Hyun Min , Palmer, Nicholette D. , Smith, Jennifer A , Lubitz, Steven A , Smith, Albert V , Kelly, Tanika N , Weeks, Daniel E , Palmer, Nicholette D , Mathias, Rasika A , Cade, Brian E , Lasky-Su, Jessica , Andrade, Mariza de , Barnard, John , Blangero, John , Burchard, Esteban G. , Chasman, Daniel I. , Cupples, L. Adrienne , Ellinor, Patrick T. , Guo, Xiuqing , Kooperberg, Charles , Mak, Angel C. Y. , Manichaikul, Ani , Montgomery, Courtney G. , Peloso, Gina M. , Roden, Dan M. , Weiss, Scott T. , Group, TOPMed Analysis Working, Abecasis, Gonçalo R.

Mayo Clinic

Genetics | March 15, 2021 | Volume: 218 | Issue: 1 | Pages: No page available

10.1093/genetics/iyab044 | PMID 33720349 Get It

Abstract Traditional Hardy–Weinberg equilibrium (HWE) tests (the χ2 test and the exact test) have long been used as a metric for evaluating genotype quality, as technical artifacts leading to incorrect genotype calls often can be identified as deviations from HWE. However, in data sets composed of individuals from diverse ancestries, HWE can be violated even without genotyping error, complicating the use of HWE testing to assess genotype data quality. In this manuscript, we present the Robust Unified Test for HWE (RUTH) to test for HWE while accounting for population structure and genotype uncertainty, and to evaluate the impact of population heterogeneity and genotype uncertainty on the standard HWE tests and alternative methods using simulated and real sequence data sets. Our results demonstrate that ignoring population structure or genotype uncertainty in HWE tests can inflate false-positive rates by many orders of magnitude. Our evaluations demonstrate different tradeoffs between false positives and statistical power across the methods, with RUTH consistently among the best across all evaluations. RUTH is implemented as a practical and scalable software tool to rapidly perform HWE tests across millions of markers and hundreds of thousands of individuals while supporting standard VCF/BCF formats. RUTH is publicly available at https://www.github.com/statgen/ruth.
Fascia Iliaca Block for Postoperative Pain Control After Hip Arthroscopy: A Systematic Review of Randomized Controlled Trials
Smith, John-Rudolph H. , Kraeutler, Matthew J. , Keeling, Laura E. , Scillia, Anthony J. , McCarty, Eric C. , Mei-Dan, Omer , Smith, John R. , McCarty, Eric C , Smith, John-Rudolph

Mayo Clinic

The American Journal of Sports Medicine | March 12, 2021 | Volume: 49 | Issue: 14 | Pages: 4042-4049

10.1177/0363546521996713 | PMID 33710936 Get It

Background: Various analgesic modalities have been used to improve postoperative pain in patients undergoing hip arthroscopy. Purpose: To systematically review the literature to compare the efficacy of the fascia iliaca block (FIB) with that of other analgesic modalities after hip arthroscopy in terms of postoperative pain scores and analgesic consumption. Study Design: Systematic review. Methods: A systematic review was performed by searching PubMed, the Cochrane Library, and Embase up to April 2020 to identify randomized controlled trials that compared postoperative pain and analgesic consumption in patients after hip arthroscopy with FIB versus other pain control modalities. The search phrase used was “hip arthroscopy fascia iliaca randomized.” Patients were evaluated based on postoperative pain scores and total postoperative analgesic consumption. Results: Five studies (3 level 1, 2 level 2) were identified that met inclusion criteria, including 157 patients undergoing hip arthroscopy with FIB (mean age, 38.3 years; 44.6% men) and 159 patients among the following comparison groups: lumbar plexus block (LPB), intra-articular ropivacaine (IAR), local anesthetic infiltration (LAI), saline placebo, and a no-block control group (overall mean age, 36.2 years; 36.5% men). No significant differences in pain scores were reported in the postanesthesia care unit (PACU) between the FIB and LPB (3.4 vs 2.9; P = .054), IAR (7.7 vs 7.9; P = .72), control group (no FIB: 4.1 vs 3.8; P = .76); or saline placebo (difference, –0.2 [95% CI, –1.1 to 0.7]). One study reported significantly higher pain scores at 1 hour postoperation in the FIB group compared with the LAI group (5.5 vs 3.4; P = .02). Another study reported significantly greater total analgesic consumption (in morphine equivalent dosing) in the PACU among the FIB group compared with the LPB group (20.8 vs 17.0; P = .02). No significant differences were observed in total PACU analgesic consumption between FIB and other analgesic modalities. Conclusion: In patients undergoing hip arthroscopy, the FIB does not appear to demonstrate superiority to other forms of analgesics in the immediate postoperative period. Therefore, it is not recommended as a routine form of pain control for these procedures.
Contralateral Rerouting of Hypoglossal Nerve Implant Pulse Generator and Stimulation Lead
Macielak, Robert J. , Olson, Eric J. , Junna, Mithri R. , Olson, Michael D.

Mayo Clinic

The Laryngoscope | March 12, 2021 | Volume: 131 | Issue: 7 | Pages: No page available

10.1002/lary.29463 | PMID 33710618 Get It

AbstractAs use of hypoglossal nerve stimulators has become more widespread in the treatment of obstructive sleep apnea, certain scenarios have dictated alterations to the previously described surgical technique. This report describes a situation in which revision of a hypoglossal nerve stimulator implant was required given the need for breast cancer surgery. It serves as the first description of the contralateral rerouting of a stimulation lead to a left‐sided impulse generator and the first description of respiratory sensing lead placement within the left second intercostal space for such a device. Laryngoscope, 131:E2409–E2412, 2021
Segregation of functional networks is associated with cognitive resilience in Alzheimer’s disease
Ewers, Michael , Luan, Ying , Frontzkowski, Lukas , Rubinski, Anna , Dichgans, Martin , Hassenstab, Jason , Gordon, Brian A. , Chhatwal, Jasmeer P. , Xiong, Chengjie , Morris, John C. , Goate, Alison , Fagan, Anne M. , Berman, Sarah , Chui, Helena C., Cruchaga, Carlos , Farlow, Marty, Graff‐Radford, Neill R. , Martins, Ralph N. , Mori, Hiroshi , Perrin, Richard J. , Xiong, Chengjie , Fox, Nick C. , O’Connor, Antoinette , Salloway, Stephen , Danek, Adrian , Büerger, Katharina , Bateman, Randall J. , Habeck, Christian , Network, for the Alzheimer’s Disease Neuroimaging Initiative and the Dominantly Inherited Alzheimer, Vöglein, Jonathan , Gordon, Brian A , O'Connor, Antoinette , Stern, Yaakov , Franzmeier, Nicolai , Dichgans, Martin , Cruchaga, Carlos , Bateman, Randall J , Vöglein, Jonathan , Xiong, Chengjie , Fox, Nick C , Hassenstab, Jason , Morris, John C , Goate, Alison M , Berman, Sarah , Neitzel, Julia , Schofield, Peter R. , Benzinger, Tammie L.S. , Karch, Celeste M. , McDade, Eric , Allegri, Ricardo , Chui, Helena C. , Jucker, Mathias , Lee, Jae‐Hong , Rossor, Martin N. , Stern, Yaakov , Franzmeier, Nicolai , Network, for the Alzheimer’s Disease Neuroimaging Initiative and the Dominantly Inherited Alzheimer

Mayo Clinic

Brain | March 12, 2021 | Volume: 144 | Issue: 7 | Pages: 2176-2185

10.1093/brain/awab112 | PMID 33725114 Get It

Abstract Cognitive resilience is an important modulating factor of cognitive decline in Alzheimer’s disease, but the functional brain mechanisms that support cognitive resilience remain elusive. Given previous findings in normal ageing, we tested the hypothesis that higher segregation of the brain’s connectome into distinct functional networks represents a functional mechanism underlying cognitive resilience in Alzheimer’s disease. Using resting-state functional MRI, we assessed both resting-state functional MRI global system segregation, i.e. the balance of between-network to within-network connectivity, and the alternate index of modularity Q as predictors of cognitive resilience. We performed all analyses in two independent samples for validation: (i) 108 individuals with autosomal dominantly inherited Alzheimer’s disease and 71 non-carrier controls; and (ii) 156 amyloid-PET-positive subjects across the spectrum of sporadic Alzheimer’s disease and 184 amyloid-negative controls. In the autosomal dominant Alzheimer’s disease sample, disease severity was assessed by estimated years from symptom onset. In the sporadic Alzheimer’s sample, disease stage was assessed by temporal lobe tau-PET (i.e. composite across Braak stage I and III regions). In both samples, we tested whether the effect of disease severity on cognition was attenuated at higher levels of functional network segregation. For autosomal dominant Alzheimer’s disease, we found higher functional MRI-assessed system segregation to be associated with an attenuated effect of estimated years from symptom onset on global cognition (P = 0.007). Similarly, for patients with sporadic Alzheimer’s disease, higher functional MRI-assessed system segregation was associated with less decrement in global cognition (P = 0.001) and episodic memory (P = 0.004) per unit increase of temporal lobe tau-PET. Confirmatory analyses using the alternate index of modularity Q revealed consistent results. In conclusion, higher segregation of functional connections into distinct large-scale networks supports cognitive resilience in Alzheimer’s disease.
Abstract 8: Retinopathy is Associated With Stroke, Dementia, and Mortality
Markovic, Daniela , Ertekin‐Taner, Nilüfer , Eggenberger, Eric , Stewart, Michael W., Brott, Thomas G. , Lin, Michelle , Meschia, James F.

Mayo Clinic

Stroke | March 11, 2021 | Volume: 52 | Issue: Suppl_1 | Pages: No page available

10.1161/str.52.suppl_1.8 Get It

Introduction: Retinal microvascular abnormalities have been associated with stroke, but their association with dementia and death is less well described. We tested the hypothesis that retinopathy is associated with stroke, dementia, and age-adjusted mortality. Methods: Data were obtained from the US National Health and Nutrition Examination Surveys from 2005 to 2008, with linked mortality through 2015. Severity of retinopathy was defined as no retinopathy, mild nonproliferative retinopathy (NPR), moderate-severe NPR, and proliferative retinopathy. Logistic regression models were performed to evaluate the relationships between retinopathy, stroke, and dementia, respectively. Independent relationships between retinopathy and all-cause mortality were assessed using Cox regression models, before and after adjusting for covariates. All analyses were adjusted for the complex survey design. Results: Of 5,543 participants aged ≥18 years with gradable retinal imaging, 696 had retinopathy, 289 had stroke, and 597 had dementia. Mean age of subjects was 56.3 ± 11.7 years. Retinopathy was associated with higher risk of stroke (adj OR 2.39, P <0.001) and dementia (adj OR 1.68, P =0.005). Over a median duration of 118 months (IQR 111-125), there was a dose-dependent relationship between severity of retinopathy and all-cause mortality (adjusted hazard ratios were 1.0, 1.5, 2.4, 3.4 across retinopathy severity; P =0.021). The Figure shows the age-adjusted cumulative mortality curves by retinopathy severity. Conclusions: Participants with retinopathy have a greater than 2-fold increase in stroke risk and a 1.7-fold increase in dementia risk. Having more severe retinopathy confers a higher risk of death after adjusting for age and vascular risk factors. The retina may serve as a tissue biomarker in intervention trials for cerebrovascular and neurodegenerative diseases.
Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Benson, Al B. , Al-Hawary, Mahmoud M. , Arain, Mustafa A., Chen, Yi‐Jen , Ciombor, Kristen K. , Cooper, Harry S. , Deming, Dustin A. , Farkas, Linda M., Garrido‐Laguna, Ignacio , Grem, Jean L. , Hecht, J. Randolph, Hoffe, Sarah E. , Hunt, Steven R., Johung, Kimberly L. , Kirilcuk, Natalie, Krishnamurthi, Smitha , Messersmith, Wells A. , Meyerhardt, Jeffrey A. , Mulcahy, Mary F. , Nurkin, Steven, Overman, Michael J. , Patel, Hitendra , Pedersen, Katrina S. , Shibata, David , Skibber, John M., Sofocleous, Constantinos T. , Stotsky‐Himelfarb, Eden, Willett, Christopher G. , Gregory, Kristina M., Gurski, Lisa A., Hubbard, Joleen, Meyerhardt, Jeffrey A , Pedersen, Katrina , Venook, Alan P. , Cohen, Stacey A. , Gunn, Andrew, Hubbard, Joleen M. , Miller, Eric D. , Parikh, Aparna R. , Patel, Hitendra, Saltz, Leonard B. , Schneider, Charles John , Stoffel, Elena M.

Mayo Clinic

Journal of the National Comprehensive Cancer Network | March 5, 2021 | Volume: 19 | Issue: 3 | Pages: 329-359

10.6004/jnccn.2021.0012 | PMID 33724754 Get It

This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer focuses on systemic therapy options for the treatment of metastatic colorectal cancer (mCRC), because important updates have recently been made to this section. These updates include recommendations for first-line use of checkpoint inhibitors for mCRC, that is deficient mismatch repair/microsatellite instability-high, recommendations related to the use of biosimilars, and expanded recommendations for biomarker testing. The systemic therapy recommendations now include targeted therapy options for patients with mCRC that is HER2-amplified, or BRAF V600E mutation–positive. Treatment and management of nonmetastatic or resectable/ablatable metastatic disease are discussed in the complete version of the NCCN Guidelines for Colon Cancer available at NCCN.org . Additional topics covered in the complete version include risk assessment, staging, pathology, posttreatment surveillance, and survivorship.
Contemporary Surgical Management of Juvenile Nasopharyngeal Angiofibroma
Cohen-Cohen, Salomón , Scheitler, Kristen M. , Janus, Jeffrey R. , Moore, Eric J. , Kasperbauer, Jan L. , Cloft, Harry J. , Link, Michael J., Gompel, Jamie J. Van , Janus, Jeffrey, Van Gompel, Jamie J , Choby, Garret

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | March 3, 2021 | Volume: 83 | Issue: S 02 | Pages: e266-e273

10.1055/s-0041-1725031 | PMID 35832970 Get It

Abstract Objectives Juvenile nasopharyngeal angiofibromas (JNAs) are uncommon tumors with an evolving treatment paradigm. The objective of this study was to compare our prior experience reported in 2005 with our most contemporary series to compare practice improvements and the impact of expanded endonasal procedures. Design Retrospective review comparing a contemporary 22 patients with JNA who underwent surgical management between 2005 and 2019, compared with a historical cohort of 65 patients from the same center. Results The most common presenting symptom was epistaxis (68%). The median maximum tumor diameter was 4.4 cm. All patients underwent preoperative embolization. An endoscopic endonasal approach (EEA) was used in 18 patients (82%), compared with 9% in the series prior to 2005. Gross total resection was achieved in all patients. The median estimated blood loss was 175 and 350 mL for EEA and open (transfacial) cases, respectively. Only two patients (9%) required a blood transfusion compared with 52% on the previous series. The median follow-up was 19 months. The overall recurrence rate was 9% in this series and 24% in the previous series. No patient required radiation therapy in follow-up compared with 3% in our historical cohort. Conclusion There have been significant changes regarding the management of patients with JNA compared with the previous Mayo Clinic experience. The EEA has become the preferred route over the transfacial approaches to treat JNA in selected patients who do not have intracranial extension. Preoperative embolization has aided in reducing the postoperative transfusion rates.